GYNOFLOR

This brand name is authorized in Cyprus, Ecuador, Hong Kong SAR China, Poland, Turkey.

Active ingredients

The drug GYNOFLOR contains a combination of these active pharmaceutical ingredients (APIs):

1	Estriol UNII FB33469R8E - ESTRIOL
	Estriol is a steroid, a weak estrogen, specifically an agonist of the estrogen receptors ERα and ERβ. It is one of three major endogenous estrogens, the others being estradiol and estrone.
	Read more about Estriol
2	Lactic acid bacteria UNII 1PRR1V42V5 - LACTOBACILLUS ACIDOPHILUS
	Read more about Lactic acid bacteria

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G01AX	Other antiinfectives and antiseptics	G Genito urinary system and sex hormones → G01 Gynecological antiinfectives and antiseptics → G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS
Discover more medicines within G01AX
G03CC06	Estriol	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03C Estrogens → G03CC Estrogens, combinations with other drugs
Discover more medicines within G03CC06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	5609-MEE-1020
HK	Department of Health Drug Office	54191
PL	Rejestru Produktów Leczniczych	100124087
TR	İlaç ve Tıbbi Cihaz Kurumu	8699514100027, 8699514100089